No results for ‘’
Hindustan Organic Chemicals Ltd
₹36.90
(0.63%)
Fri, 18 Sept 2026, 01:32 am
Process Industries
Chemicals: Specialty
24.5KHindustan Organic Chemicals EV/EBITDA Ratio
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 13.50 | 16.89 | 0 | 0 | 8.25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.13 | 0 | 105.20 | 0 | 0 | 0 | 0.73 |
| Price to book ratio | 0 | 1.41 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.39 | 4.53 | 1.39 | 3.85 | 8.45 | 0 | 0 | 0 | 0.27 |
| Price to sales ratio | 0.65 | 0.46 | 0.46 | 0.23 | 0.53 | 0.33 | 0.22 | 0.13 | 0.38 | 0.54 | 0.78 | 0.94 | 0.56 | 0.31 | 0.20 | 0.65 | 0.43 | 0.24 | 0.37 | 0.53 |
| Price to cash flow ratio | 0 | 0 | 19.12 | 0 | 0 | 4.08 | 0 | 0 | 0 | 0 | 0 | 2.77 | 0 | 0 | 0 | 0 | 17.90 | 16.19 | 0 | 0.45 |
| Enterprise value | 682Cr | 361Cr | 628Cr | 579Cr | 745Cr | 651Cr | 585Cr | 571Cr | 606Cr | 780Cr | 811Cr | 852Cr | 816Cr | 865Cr | 716Cr | 613Cr | 811Cr | 730Cr | 808Cr | 202Cr |
| Enterprise value to EBITDA ratio | 0 | 12.18 | 16.55 | 0 | 0 | 10.34 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30.82 | 0 | 16.95 | 32.48 | 104.92 | 0 | 0 |
| Debt to equity ratio | 0 | 1.36 | 0.92 | 1.56 | 3.99 | 2.12 | 25.42 | 0 | 0 | 0 | 0 | 5.93 | 22.88 | 7.22 | 44.54 | 16.70 | 0 | 0 | 0 | 0.20 |
| Return on equity % | 0 | 85.75 | 9.01 | -16.08 | -78.31 | 34.76 | -157.39 | 0 | 0 | 0 | 0 | 0 | -243.13 | 99.88 | -150.20 | 10.35 | -221.57 | 0 | 0 | 78.79 |
Hindustan Organic Chemicals Ltd Enterprise Value to EBITDA Ratio
The Hindustan Organic Chemicals Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Hindustan Organic Chemicals Ltd's valuation, profitability, and overall financial performance. Tracking the Hindustan Organic Chemicals Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Hindustan Organic Chemicals Ltd (NSE: HOCL, BSE: 500449) is currently trading at ₹36.90, with a market capitalization of ₹247.67Cr. As a leading company in the Process industries sector and Chemicals: specialty industry, monitoring the Hindustan Organic Chemicals Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.
Hindustan Organic Chemicals Ltd Enterprise Value to EBITDA Ratio Current Value
The current Hindustan Organic Chemicals Ltd Enterprise Value to EBITDA Ratio stands at 0.
The Hindustan Organic Chemicals Ltd Enterprise Value to EBITDA Ratio remains stable, indicating consistent financial performance.
Hindustan Organic Chemicals Ltd Enterprise Value to EBITDA Ratio Historical Trend
The Hindustan Organic Chemicals Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:
- 2024: 0
- 2023: 0
- 2022: 104.92
- 2021: 32.48
- 2020: 16.95
The decline in Hindustan Organic Chemicals Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.
What Hindustan Organic Chemicals Ltd Enterprise Value to EBITDA Ratio Indicates for Investors
The Hindustan Organic Chemicals Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Hindustan Organic Chemicals Ltd.
Hindustan Organic Chemicals Ltd Enterprise Value to EBITDA Ratio Analysis Summary
The Hindustan Organic Chemicals Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Hindustan Organic Chemicals Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Hindustan Organic Chemicals Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.